ArticleJNCI cancer spectrum2026
Phthalates measured at birth and risk of testicular cancer in adolescents and young adults.
Article in JNCI cancer spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe incidence rates of testicular germ cell tumors (TGCT) are increasing in adolescents and young adults in the United States, especially in Latinos. We investigated the association between TGCT risk and birth levels of phthalates, known endocrine disrupting chemicals, in a diverse population in California.
methodsReverse phase chromatography was applied to newborn blood samples of 196 TGCT cases and 190 controls to measure 10 phthalates, 5 of which passed quality control: mono-2-methyl-2-hydroxypropyl phthalate/mono-3-hydroxy butylphthalate (MHiBP/MHBP), mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-(oxo-isononyl) phthalate (MOiNP), and mono(2-ethylhexyl) phthalate (MEHP). We conducted single chemical and mixture analyses using weighted quantile sum (WQS) regression, adjusting for birth and sociodemographic characteristics, and hematocrit. We ran repeated holdout analyses splitting data between training and testing sets 100 times.
resultsNone of the single phthalates was significantly related to case status. The overall WQS analyses showed a curvilinear mixture effect related to TGCT risk, approximated with linear and quadratic terms, and dominated by MECPP and MEHP mostly in the lower concentration ranges. For Latinos, the curvilinear mixture effect was dominated by MEHP, and the WQS betas were borderline significant (median b1 = 0.37, 95% CI = -0.25 to 1.28; median b1sq = -0.04, 95% CI = -0.15 to 0.03), with a high level of reproducibility for beta estimations in the repeated analyses (87%-89%). For non-Latino whites, the mixture effect was dominated by MECPP and MHiBP/MHBP, although the signal for curvilinearity and repeated analyses were less robust.
conclusionsPrenatal exposure to phthalate mixtures may increase TGCT risk later in life, with some variation by racial/ethnic group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.